In line with emerging biomarkers of interest, baseline HER2 tissue-based biomarkers examined intrinsic subtype, HER2 expression by IHC and HER2 tumor protein abundance by digital spatial profiling with a summary of results presented in Supplementary Table 1. This evidence concerns the gene ERBB2 and neoplasm.